International Clinical Trial: A prospective, single-arm, clinical study of finolizumab combined with TP induction regimen in the treatment of resectable locally advanced hypopharyngeal squamous cell carcinoma

Geneva, April 20 -- International Clinical Trials Registry received information related to the study (ChiCTR2600121672) titled 'A prospective, single-arm, clinical study of finolizumab combined with TP induction regimen in the treatment of resectable locally advanced hypopharyngeal squamous cell carcinoma' on April 1.

Study Type: Interventional study

Study Design: Single arm

Primary Sponsor: The First Affiliated Hospital of Fujian Medical University

Condition: Hypopharyngeal squamous cell carcinoma 2B6D.0

Recruitment Status: Recruiting

Phase: 1

Date of First Enrollment: 2026-04-01

Target Sample Size: Experimental Group:30;

Countries of Recruitment: China PR

To know more, visit https://www.chictr.org.cn/showproj.html?proj=3...